Research Article

FTY720 Increases Doxorubicin Sensitivity in Resistant Acute Myeloid Leukemia Cells

DOI:

10.3791/71676

July 7th, 2026

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This protocol evaluates how FTY720 increases doxorubicin sensitivity in resistant acute myeloid leukemia cells by assessing cell viability, apoptosis, intracellular doxorubicin accumulation, drug-efflux transporter expression, and protein kinase B/mechanistic target of rapamycin signaling.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Chemoresistance remains a major barrier to effective treatment of acute myeloid leukemia, partly because resistant leukemic cells reduce intracellular drug exposure and evade apoptosis. FTY720, a sphingosine-1-phosphate receptor modulator, has reported antiproliferative and chemosensitizing activity in several tumor models. However, whether FTY720 increases doxorubicin sensitivity in doxorubicin-resistant acute myeloid leukemia cells, and whether this effect is associated with changes in drug-efflux transporters and protein kinase B/mechanistic target of rapamycin signaling, remains insufficiently defined. This study evaluated the effects of FTY720 alone and in combination with doxorubicin in parental acute myeloid leukemia cell lines (HL60 and K562) and their doxorubicin-resistant derivatives (HL60/A and K562/A). Cell viability was assessed using Cell Counting Kit-8 assays, apoptosis was measured by Annexin V/propidium iodide flow cytometry, intracellular doxorubicin accumulation was quantified by flow cytometry, and P-glycoprotein, multidrug resistance-associated protein 1, protein kinase B/mechanistic target of rapamycin pathway proteins, and apoptosis-related proteins were examined by flow cytometry and Western blotting. FTY720 showed dose-dependent cytotoxicity and increased doxorubicin sensitivity in resistant leukemia cells. Combined treatment reduced cell viability, increased apoptotic cell fractions, enhanced intracellular doxorubicin accumulation, and decreased P-glycoprotein and multidrug resistance-associated protein 1 expression. FTY720 treatment was also associated with reduced phosphorylation of protein kinase B and mechanistic target of rapamycin, whereas the protein kinase B activator SC79 partially reversed the observed changes in signaling, transporter expression, and apoptosis. These findings indicate that FTY720 increases doxorubicin sensitivity in HL60/A and K562/A cells and that this effect is associated with reduced protein kinase B/mechanistic target of rapamycin signaling, decreased drug-efflux transporter expression, enhanced intracellular doxorubicin accumulation, and increased apoptosis. Because this study was limited to in vitro cell-line models, further validation in primary leukemia samples and in vivo systems is required before therapeutic conclusions can be drawn.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Acute myeloid leukemia is a heterogeneous hematological malignancy arising from the malignant transformation of hematopoietic stem and progenitor cells. It is the most common form of acute leukemia in adults and remains associated with poor long-term survival. Although treatment strategies have improved, induction chemotherapy based on cytarabine combined with an anthracycline remains a cornerstone of treatment. However, many patients develop primary or acquired resistance, leading to relapse, refractory disease, and poor clinical outcomes1,2,3. Understanding the mechanisms t....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This study was performed using established human acute myeloid leukemia cell lines and their doxorubicin-resistant derivatives. No human participants, animals, or primary patient-derived samples were involved. Therefore, institutional review board approval for human-subject research and animal ethics approval were not required. The cell lines were obtained from the Institute of Hematology, Chinese Academy of Medical Sciences, Tianjin, China, and maintained at the Fujian Institute of Hematology, Fujian Medical University Union Hospital. Cell identity was confirmed by karyotype and morphological assessment prior to experimentation, and all cell cultures were tested for ....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

FTY720 reduced the viability of parental and doxorubicin-resistant acute myeloid leukemia cells

HL60, K562, HL60/A, and K562/A cells were exposed to increasing concentrations of FTY720 (0, 3.125, 6.25, 12.5, 25, 50, and 100 µM) for 48 h, and cell viability was measured using the Cell Counting Kit-8 assay. FTY720 reduced cell viability in all four cell lines in a concentration-dependent manner (Figure 1A). The calculated half-maximal inhibitory con.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Chemoresistance remains one of the major barriers to effective acute myeloid leukemia treatment. In patients who fail to respond to induction therapy or develop relapse after initial response, resistant leukemia cells can persist despite exposure to cytarabine- and anthracycline-based regimens, making the identification of approaches that increase drug sensitivity an important experimental and clinical question23. Doxorubicin is an anthracycline with broad antitumor activity, but its clinical use .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors declare no competing interests.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This work was supported by the Fujian Natural Science Foundation (Grant No. 2022J01257).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
6-well tissue culture platesCorning / Costar3516 or laboratory-verified equivalentUsed for treatment, apoptosis, doxorubicin accumulation, and protein-expression experiments.
96-well tissue culture platesCorning / Costar3599 or laboratory-verified equivalentUsed for Cell Counting Kit-8 assays.
Alexa Fluor 647 mouse immunoglobulin G1 isotype controlBioLegend400130 or laboratory-verified equivalentIsotype control for Alexa Fluor 647-conjugated antibody staining. Use the exact catalog number from the reagent vial.
Alexa Fluor 647-conjugated anti-human multidrug resistance-associated protein 1 / ABCC1 antibodyBioLegend370103Used for flow cytometric detection of multidrug resistance-associated protein 1. Product availability should be confirmed because some BioLegend MRP1 formats have been discontinued or replaced.
Annexin V apoptosis detection kit with propidium iodideBioLegend640914 or laboratory-verified equivalentUsed for Annexin V and propidium iodide apoptosis analysis by flow cytometry. If Annexin V-allophycocyanin was used instead of Annexin V-fluorescein isothiocyanate, replace this with the exact kit catalog number.
Bicinchoninic acid protein assay kitThermo Fisher Scientific / Beyotime / laboratory-verified supplierUse the actual catalog numberUsed for protein concentration measurement.
Carbon dioxide cell culture incubatorThermo Fisher Scientific / Eppendorf / laboratory-verified instrumentModel to be inserted from laboratory recordMaintained cells at 37 °C and 5% carbon dioxide.
Caspase-3 antibodyCell Signaling Technology9662; RRID:AB_331439Detects full-length and cleaved caspase-3 by Western blot. If a cleaved caspase-3-specific antibody was used, replace with the exact catalog number.
Cell Counting Kit-8Dojindo Molecular TechnologiesCK04Used for cell viability and half-maximal inhibitory concentration assays.
Cell staining bufferBioLegend420201Used for antibody dilution and washing during flow cytometric staining.
Cleaved poly(adenosine diphosphate-ribose) polymerase antibodyCell Signaling Technology94885; RRID:AB_2800237Western blot antibody for cleaved poly(adenosine diphosphate-ribose) polymerase.
CompuSynComboSyn, Inc.Version 1.0 or laboratory-verified versionUsed for Chou-Talalay combination-index analysis if complete combination-dose data are available.
Dimethyl sulfoxideSigma-Aldrich / MerckD2650 or laboratory-verified equivalentVehicle for FTY720 and SC79 stock solutions; final concentration did not exceed 0.1%.
Doxorubicin hydrochlorideUse the actual supplier from the laboratory purchase recordUse the actual catalog number and lot numberAnthracycline used for resistance maintenance and treatment assays. This entry must match the reagent actually used in the experiments.
Enhanced chemiluminescence substrateThermo Fisher Scientific / MilliporeSigma / laboratory-verified supplierUse the actual catalog numberUsed for Western blot signal detection.
Fetal bovine serumGibco, Thermo Fisher Scientific10099-141 or laboratory-verified equivalentAdded to culture medium at 10%. Use heat-inactivated or non-heat-inactivated serum consistently across all experiments.
Flow cytometerBD BiosciencesBD FACScan or actual instrument modelUsed for apoptosis, intracellular doxorubicin accumulation, and transporter-expression assays. Record laser/filter configuration in the supplementary methods if available.
Flow cytometry analysis softwareBD Biosciences / FlowJo / laboratory-verified softwareVersion to be inserted from laboratory recordUsed for compensation, gating, and median fluorescence intensity analysis.
FTY720 / fingolimod hydrochlorideUse the actual supplier from the laboratory purchase recordUse the actual catalog number and lot numberDrug-treatment reagent. This entry must match the reagent actually used in the experiments. Do not replace with a different supplier unless the experiment was performed with that product.
Glyceraldehyde-3-phosphate dehydrogenase antibodyAbcamab181602Loading control for Western blot. Confirm RRID from the product insert before submission.
GraphPad PrismGraphPad SoftwareVersion 9.5Used for dose-response curve fitting, half-maximal inhibitory concentration calculation, and statistical analysis.
HL60 human acute myeloid leukemia cellsInstitute of Hematology, Chinese Academy of Medical Sciences, Tianjin, ChinaNot commercially catalogued in this studyHuman acute myeloid leukemia parental cell line; authenticated by karyotype and morphology before use. If a public reference is required, HL60 corresponds to RRID:CVCL_0002.
HL60/A doxorubicin-resistant cellsInstitute of Hematology, Chinese Academy of Medical Sciences, Tianjin, ChinaNot commercially cataloguedDoxorubicin-resistant derivative of HL60 cells; maintained at the Fujian Institute of Hematology. Resistance was maintained with 1 µg/mL doxorubicin before drug-free culture.
Horseradish peroxidase-conjugated anti-rabbit immunoglobulin G secondary antibodyCell Signaling Technology / Abcam / laboratory-verified supplierUse the actual catalog numberSecondary antibody for Western blot. Insert exact supplier and catalog number from laboratory records.
IBM SPSS StatisticsIBMVersion 23.0Used for statistical analysis.
ImageJNational Institutes of HealthVersion 1.53tUsed for Western blot densitometric quantification.
K562 human leukemia cellsInstitute of Hematology, Chinese Academy of Medical Sciences, Tianjin, ChinaNot commercially catalogued in this studyHuman leukemia parental cell line; authenticated by karyotype and morphology before use. If a public reference is required, K562 corresponds to RRID:CVCL_0004.
K562/A doxorubicin-resistant cellsInstitute of Hematology, Chinese Academy of Medical Sciences, Tianjin, ChinaNot commercially cataloguedDoxorubicin-resistant derivative of K562 cells; maintained at the Fujian Institute of Hematology. Resistance was maintained with 5 µg/mL doxorubicin before drug-free culture.
Microplate readerBioTek / Thermo Fisher Scientific / Molecular Devices / laboratory-verified instrumentModel to be inserted from laboratory recordUsed to measure absorbance at 450 nm for Cell Counting Kit-8 assays.
Multidrug resistance-associated protein 1 antibody for Western blotCell Signaling Technology72202Used for Western blot detection of multidrug resistance-associated protein 1. Confirm RRID from the product insert or Antibody Registry before submission.
Penicillin-streptomycin solutionGibco, Thermo Fisher Scientific15140122 or laboratory-verified equivalentAdded to complete medium at 1%.
P-glycoprotein / MDR1 / ABCB1 antibody for Western blotCell Signaling Technology13978; RRID:AB_2798357Used for Western blot detection of P-glycoprotein.
Phosphate-buffered salineGibco, Thermo Fisher Scientific10010023 or laboratory-verified equivalentUsed for cell washing and sample preparation.
Phosphorylated mechanistic target of rapamycin antibodyCell Signaling Technology2971; RRID:AB_330970Western blot antibody for phosphorylated mechanistic target of rapamycin at Ser2448.
Phosphorylated protein kinase B antibodyCell Signaling Technology4060; RRID:AB_2315049Western blot antibody for phosphorylated protein kinase B at Ser473.
Phycoerythrin mouse immunoglobulin G2a isotype controlBioLegend400213Isotype control for phycoerythrin-conjugated antibody staining. Confirm the isotype matches the anti-P-glycoprotein antibody used.
Phycoerythrin-conjugated anti-human P-glycoprotein / CD243 / ABCB1 antibodyBioLegend919405Used for flow cytometric detection of P-glycoprotein. Include clone and RRID if confirmed from the product insert.
Polyvinylidene difluoride membraneMilliporeSigmaIPVH00010 or laboratory-verified equivalentUsed for Western blot transfer.
Protease and phosphatase inhibitor cocktailThermo Fisher Scientific / Roche / laboratory-verified supplierUse the actual catalog numberAdded to lysis buffer before protein extraction.
Radioimmunoprecipitation assay lysis bufferBeyotime / Thermo Fisher Scientific / laboratory-verified supplierUse the actual catalog numberUsed for total protein extraction.
Roswell Park Memorial Institute 1640 mediumHyClone / CytivaSH30809.01 or laboratory-verified equivalentBasal culture medium for all leukemia cell lines. Use the exact catalog number from the laboratory purchase record if different.
SC79, protein kinase B activatorUse the actual supplier from the laboratory purchase recordUse the actual catalog number and lot numberUsed in rescue experiments. The manuscript should consistently report the same final SC79 concentration across Protocol, Results, and Figure 6 legend.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis reagentsBio-Rad / Beyotime / laboratory-verified supplierUse the actual catalog numberUsed for Western blot protein separation.
Total mechanistic target of rapamycin antibodyCell Signaling Technology2972; RRID:AB_330978Western blot antibody for total mechanistic target of rapamycin.
Total protein kinase B antibodyCell Signaling Technology4691; RRID:AB_915783Western blot antibody for total protein kinase B.
Western blot imaging systemBio-Rad / Cytiva / laboratory-verified instrumentModel to be inserted from laboratory recordUsed for enhanced chemiluminescence image acquisition.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

MedicineAKT mTOR

Related Articles